Table 1 Background information of localized gastric MALT lymphoma analyzed in this study.
Gastric MALT lymphoma (n = 131) | ||
|---|---|---|
Average age, years ± SD | 63.6 ± 11.42 | |
Sex | Male | 60 (46) |
Female | 71 (54) | |
Hp infection | Current | 54 (41.2) |
Previous | 25 (19.1) | |
Uninfected | 52 (39.7) | |
Mucosal atrophy | None | 52 (39.7) |
Closed type | 39 (29.8) | |
Open type | 40 (30.5) | |
Locations in the stomach | L | 21 (16.0) |
M | 68 (52.3) | |
U | 25 (19.2) | |
M/L | 7 (5.4) | |
U/M | 3 (2.3) | |
U/L | 1 (0.8) | |
U/M/L | 6 (4.6) | |
Number of lesions | Single | 55 (42.0) |
Multiple | 76 (58.0) | |
Morphological type | Superficial | 103 (78.6) |
Submucosal tumor | 12 (9.2) | |
Nodular gastritis-like | 6 (4.6) | |
Ulceration | 5 (3.8) | |
Others | 5 (3.8) | |
BIRC3-MALT1 fusion gene | Positive | 36 (28.1) |
Negative | 95 (72.5) | |
Efficacy of eradication therapy | CR | 63 (49.6) |
NC | 64 (50.4) | |
Treatment | Eradication only | 68 (51.9) |
Eradication + radiation therapy | 51 (38.9) | |
Eradication + chemotherapy | 8 (6.1) | |
Others | 4 (3.1) |
